Abstract
Background: Delayed identification of bacterial sepsis undermines the initiation of antibiotic and other time-sensitive treatments in the emergency department (ED). We aimed to investigate the performance of human-neutrophil lipocalin (HNL), procalcitonin (PCT), C-reactive protein (CRP), and leucocyte count in conjunction with clinical scores for the early detection of bacterial sepsis.
Methods: Patients presenting to the emergency department (ED) with a suspected infection and a national early warning score (NEWS) ≥2 at triage were screened for eligibility. The study biomarkers were measured at ED presentation. The primary outcome was bacterial sepsis, defined as an acute bacterial infection and an increase of ≥2 points in the sequential organ failure assessment (SOFA) score (Sepsis-3 criteria). The diagnostic accuracy of the biomarkers for bacterial sepsis was calculated using receiver operating curve (ROC) analysis and its area under the curve (AUC) with 95 % confidence intervals (CI).
Results: In total, we included 421 patients, of whom 155 (36.8%) had bacterial sepsis. For the prediction of bacterial sepsis, PCT outperformed the other biomarkers with an AUC (95% CI) of 0.77 (0.72 – 0.82), compared to HNL 0.72 (0.67 – 0.77), CRP 0.71 (0.66 - 0.76), and leucocyte count 0.64 (0.59 – 0.70). A combination of serum HNL with NEWS and SOFA at presentation had the best predictive value for bacterial sepsis (AUC 0.83).
Conclusion: A combination of biomarkers (serum HNL or CRP plus leucocytes) with NEWS and SOFA at presentation outperformed inflammatory biomarkers used individually in the prediction of bacterial sepsis.